CARsgen Therapeutics News and Activities

CARsgen Therapeutics is a company listed under the stock ticker 2171 (HK).

View the org chart displaying its 11 main executives

Most searched biographies at CARsgen Therapeutics

• Zhonghai Li, Chief Executive Officer, Chairman of the Board and Ch...
• Hua Jiang, Executive Director
• Huamao Wang, Chief Operations Officer

Create your alert
to follow the executive moves at CARsgen Therapeutics.

CARsgen Therapeutics has 2,405 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by CARsgen Therapeutics

• Publication | CARsgen
• News | CARsgen
• News | CARsgen
• News | CARsgen
• News | CARsgen
• News | CARsgen
• News | CARsgen
• News | CARsgen
• News | CARsgen
• News | CARsgen
• View more press releases Close

Social media about CARsgen Therapeutics

• CARsgen Therapeutics on Wikipedia, Google News & Yahoo Finance
• CARsgen Therapeutics on LinkedIn, X (Twitter) & YouTube